Spero Therapeutics (SPRO) Total Debt Growth (1y) (2017 - 2024)
Spero Therapeutics (SPRO) Total Debt Growth (1y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Spero Therapeutics |
129.74 Mn |
73.61 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2024 |
-79.03% |
| Jun 30, 2024 |
-65.28% |
| Mar 31, 2024 |
-55.29% |
| Dec 31, 2023 |
-9.38% |
| Sep 30, 2023 |
-75.00% |
| Jun 30, 2023 |
-68.97% |
| Mar 31, 2023 |
-92.43% |
| Dec 31, 2022 |
-30.43% |
| Sep 30, 2022 |
67.57% |
| Jun 30, 2022 |
46.84% |
| Mar 31, 2022 |
568.45% |
| Dec 31, 2021 |
-22.03% |
| Sep 30, 2021 |
-20.43% |
| Jun 30, 2021 |
-19.39% |
| Mar 31, 2021 |
-18.05% |
| Dec 31, 2020 |
-28.92% |
| Sep 30, 2020 |
-61.17% |
| Jun 30, 2020 |
-62.02% |
| Mar 31, 2020 |
-61.68% |
| Dec 31, 2019 |
11.66% |
